Lanmar

The bitcoin of Biotech is about to go down

Short
Lanmar Aggiornato   
NASDAQ:CRSP   CRISPR Therapeutics AG
I view CRSP as one of the most interesting biotechnology stocks out there. DYOR. If it works, it will be huge. I am happy to see there will be opportunities to accumulate some stock, after I short it into my ideal entry levels.
Commento:
approaching target 1
Commento:
CRSP is in long term accumulation zone. It's a buy anywhere between 32 - 24 as a long term hold.
Commento:
This trade did extremely well from an execution standpoint. The technicals are now indicating to me that price may reach close to $200 per share in the next year or two. This stock has all the signs of being a superior long term hold.

Declinazione di responsabilità

Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.